Regeneron Pharmaceuticals Inc. (REGN) UBS Biopharma Conference (Transcript)

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) UBS Biopharma Conference Call November 9, 2023 11:00 AM ET Company Participants Ryan Crowe - Vice President, Investor Relations Brook Jennings - Vice President, Immunology Marketing Conference Call Participants Colin Bristow - UBS Colin Bristow Well, good morning, and welcome to the UBS Biopharma Conference. I am Colin Bristow, one of the biotech analysts here. It's my pleasure to have Regeneron Pharmaceuticals with us today. On behalf of the company, we have Bro ...